Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefapixant on Cough Reflex Sensitivity
NCT02397460Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Apr 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefapixant in chronic cough, sponsored by Merck & Co.. Started Apr 2015; status: completed.
02
Drugs
gefapixant
03
Conditions
chronic cough
Beyond the preview
Go deeper on NCT02397460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02397460.